World's Best Scientists 2026 revealed!
Mark E. Schmidt

Mark E. Schmidt

D-Index & Metrics

Neuroscience

D-Index
40
Citations
6929
World Ranking
8062
National Ranking
96

Mark E. Schmidt publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Mark E. Schmidt sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 166 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Mark E. Schmidt D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Mark E. Schmidt sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 40 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Mark E. Schmidt is affiliated with Janssen in Belgium. Their research primarily spans the fields of Medicine and Neuroscience, with a focus on subfields such as Psychiatry and Mental Health, Physiology, Cognitive Neuroscience, Radiology, Nuclear Medicine and Imaging, and Pharmacology.

They have contributed extensively to topics including:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Functional Brain Connectivity Studies
  • Medical Imaging Techniques and Applications
  • Cannabis and Cannabinoid Research
  • Advanced MRI Techniques and Applications
  • Treatment of Major Depression

The body of published work by Mark E. Schmidt includes papers in prominent journals with multiple contributions to "Alzheimer's & Dementia" (17 publications) and "Neuropsychopharmacology" (4 publications), as well as works in "European Journal of Nuclear Medicine and Molecular Imaging," "NeuroImage," and "Molecular Psychiatry."

Notable recent publications authored or co-authored by Schmidt include:

  • The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study (2020), Neuropsychopharmacology
  • A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials (2021), Molecular Psychiatry
  • Multitracer model for staging cortical amyloid deposition using PET imaging (2020), Neurology
  • Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort (2021), Alzheimer's & Dementia
  • Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study (2020), Alzheimer's & Dementia

Frequent collaborators in their research include:

  • Juan Domingo Gispert
  • Frederik Barkhof
  • Pieter Jelle Visser
  • Lyduine E. Collij
  • Andrew Stephens

Best Publications

  • The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

    Michael W. Weiner;Michael W. Weiner;Dallas P. Veitch;Paul S. Aisen;Laurel A Beckett

  • The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans

    Michael W. Weiner;Michael W. Weiner;Paul S. Aisen;Clifford R. Jack;William J. Jagust

  • Reduced Reward Learning predicts outcome in Major Depressive Disorder

    Elske Vrieze;Diego A. Pizzagalli;Koen Demyttenaere;Titia Hompes

  • Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers

    S. M. Landau;S. M. Landau;B. A. Thomas;L. Thurfjell;M. Schmidt

  • Human PET Studies of Metabotropic Glutamate Receptor Subtype 5 with 11C-ABP688

    Simon M. Ametamey;Valerie Treyer;Johannes Streffer;Matthias T. Wyss

  • Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

    Enchi Liu;Mark E. Schmidt;Richard Margolin;Reisa Sperling

  • Dimensions in major depressive disorder and their relevance for treatment outcome.

    Elske Vrieze;Koen Demyttenaere;Ronny Bruffaerts;Dirk Hermans

  • The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data.

    Mark E. Schmidt;Ping Chiao;Gregory Klein;Dawn Matthews

  • Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology

    Jelle Praet;Nikolay V. Manyakov;Leacky Muchene;Zhenhua Mai;Zhenhua Mai

  • PET imaging shows loss of striatal PDE10A in patients with Huntington disease.

    Rawaha Ahmad;Sophie Bourgeois;Andrey Postnov;Mark E. Schmidt

  • Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging

    Lieven Denis Declercq;Frederik Rombouts;Michel Koole;Katleen Fierens

  • The effects of ECT on brain glucose: a pilot FDG PET study.

    Michael E. Henry;Mark E. Schmidt;John A. Matochik;Eve P. Stoddard

  • A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study.

    Michael E Henry;Mark E Schmidt;John Hennen;Rosemond A Villafuerte

  • Multi-tracer model for staging cortical amyloid deposition using PET imaging

    Lyduine E. Collij;Fiona Heeman;Gemma Salvadó;Silvia Ingala

  • The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.

    Mark E. Schmidt;Maurizio Fava;James M. Robinson;Rajinder Judge

  • The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study.

    Mark E. Schmidt;Michael R. Liebowitz;Murray B. Stein;Jennifer Grunfeld

  • Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort

    Silvia Ingala;Casper De Boer;Larissa A. Masselink;Ilaria Vergari

  • High Levels of Gsα in Platelets of Euthymic Patients With Bipolar Affective Disorder

    Philip B. Mitchell;Husseini K. Manji;Guang Chen;Libby Jolkovsky

  • Preclinical Evaluation of a P2X7 Receptor–Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates

    Dieter Ory;Sofie Celen;Rik Gijsbers;Chris Van Den Haute

  • Treatment approaches to major depressive disorder relapse. Part 1: dose increase.

    Mark E. Schmidt;Maurizio Fava;Shuyu Zhang;Jill Gonzales

  • 18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446

    Michel Koole;Mark E. Schmidt;Anja Hijzen;Paulien Ravenstijn

  • Preclinical Evaluation of 18F-JNJ41510417 as a Radioligand for PET Imaging of Phosphodiesterase-10A in the Brain

    Sofie Celen;Michel Koole;Meri De Angelis;Ivan Sannen

  • Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study

    Michael E. Henry;Constance M. Moore;Marc J. Kaufman;David Michelson

Frequent Co-Authors

Xavier Langlois
Xavier Langlois AbbVie (Belgium)
Frederik Barkhof
Frederik Barkhof University College London
Philip Scheltens
Philip Scheltens Amsterdam UMC
William Z. Potter
William Z. Potter National Institutes of Health
Juan Domingo Gispert
Juan Domingo Gispert Pasqual Maragall Foundation
Pieter Jelle Visser
Pieter Jelle Visser Amsterdam University Medical Centers
William J. Jagust
William J. Jagust University of California, Berkeley

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education options can open doors to diverse career pathways in neuroscience and related fields. More professionals are seeking online certificate programs that pay well to quickly boost their qualifications and earning potential. These certificates can supplement a neuroscience background and help specialize in high-demand areas like health technology or data science.

For adult learners and those managing busy schedules, there is a wide range of online classes for adults tailored to different learning needs. These programs offer flexibility, making it easier to balance studies with other responsibilities.

If your interests intersect with mental health or social work, consider exploring affordable msw programs online to expand your expertise. These programs are a cost-effective way to gain valuable credentials and move toward careers that combine neuroscience knowledge with social advocacy.

Additionally, for those interested in behavior analysis, bcba programs online offer a practical route to become a Board Certified Behavior Analyst—a role valuable in clinical, research, and educational settings.

Best Scientists Citing Mark E. Schmidt

Trending Scientists

Recently Published Articles